Bennett David A
Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, Illinois, United States of America.
PLoS Med. 2017 Mar 14;14(3):e1002256. doi: 10.1371/journal.pmed.1002256. eCollection 2017 Mar.
In a Perspective, David Bennett makes a case for neural reserve to be considered as a therapeutic endpoint in clinical trials for dementia.
在一篇《观点》文章中,大卫·贝内特提出了将神经储备作为痴呆症临床试验治疗终点的理由。